Portfolio (Quarterly)
Guide ↗
Rosalind Advisors, Inc.
· CIK 0001622627| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PCVX | VAXCYTE INC | Healthcare | 290,000.0 | $16.9M | 6.77% | NEW | — | $58.11 | -14.4% |
| 2 | VOR | VOR BIOPHARMA INC | Healthcare | 700,000.0 | $12.5M | 5.02% | NEW | — | $17.84 | -19.7% |
| 3 | CLDX | CELLDEX THERAPEUTICS INC | Healthcare | 330,000.0 | $10.5M | 4.21% | NEW | — | $31.72 | -3.3% |
| 4 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 923,057.0 | $8.8M | 3.53% | NEW | — | $9.52 | -10.9% |
| 5 | AVIR | ATEA PHARMACEUTICALS INC | Healthcare | 1,171,855.0 | $6.3M | 2.53% | NEW | — | $5.38 | -16.8% |
| 6 | OVID | OVID THERAPEUTICS INC | Healthcare | 1,107,994.0 | $2.5M | 0.99% | NEW | — | $2.22 | +9.9% |
| 7 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 125,000.0 | $2.4M | 0.95% | NEW | — | $18.90 | +20.6% |
| 8 | — | LIPOCINE INC | — | 221,616.0 | $1.8M | 0.71% | NEW | — | $7.99 | — |
| 9 | — | AVALO THERAPEUTICS INC | — | 75,000.0 | $1.1M | 0.45% | NEW | — | $14.93 | — |
| 10 | ANNX | ANNEXON INC | Healthcare | 200,000.0 | $1.1M | 0.45% | NEW | — | $5.54 | -1.7% |
| 11 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 250,000.0 | $1.0M | 0.42% | NEW | — | $4.15 | -1.0% |
| 12 | — PUT | VIRIDIAN THERAPEUTICS INC | — | 263,600.0 | $53K | 0.02% | NEW | — | $0.20 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%